Both in Biotechnology
Krystal Biotech vs ImmunityBio
Over the past year KRYS returned +89.6% and IBRX returned +243.6%; their daily moves had a correlation of 0.14.
KRYS +89.6% IBRX +243.6%Growth of $1, one year, split-adjusted
| Metric | KRYS | IBRX |
|---|---|---|
| Price | $335.06 | $8.83 |
| Market cap | $9.92B | $9.36B |
| Today | −0.60% | +3.64% |
| 1 month | −4.7% | +9.7% |
| 6 months | +35.7% | +32.6% |
| Year to date | +35.9% | +346.0% |
| 1 year | +99.7% | +247.6% |
| Revenue growth (YoY) | +24.1% | +93.9% |
| Gross margin | 94.6% | 99.4% |
| Net margin | 45.9% | −449.6% |
| P/E (TTM) | 41.1× | — |
| Price / sales | 22.5× | 56.4× |
| Net cash | $845.6M | -$57.7M |
| Dividend yield | — | — |
| Volatility (60d) | 42.6% | 60.5% |
| Short % of float | 13.9% | 31.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).